fda semaglutide news The approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 Hims & Hers stock falls

Michigan Medicaid and Insurance Coverage Michigan Medicaid (called Healthy Michigan Plan for the expanded adult population) does not currently cover GLP-1 medications for weight loss

Color me intrigued

Solution: CareValidate infrastructure enabled rapid, compliant service expansion built on the clinics existing patient relationships and clinical reputation

Trulicity injection sites Youll inject Trulicity into your abdomen, thigh, or upper arm

International Journal of Molecular Sciences, September 2018, pages 1-44 2

Image Credit: AtlasStudio / Shutterstock A recent editorial published in the journal Expert Opinion on Pharmacotherapy discussed that glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) may potentially transform health outcomes for individuals with serious mental illnesses (SMIs)